0.960
0.03 (3.23%)
| Penutupan Terdahulu | 0.930 |
| Buka | 0.950 |
| Jumlah Dagangan | 16,184 |
| Purata Dagangan (3B) | 63,779 |
| Modal Pasaran | 106,691,520 |
| Harga / Pendapatan (P/E Ke hadapan) | 116.28 |
| Harga / Jualan (P/S) | 3.66 |
| Harga / Buku (P/B) | 2.55 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 25 Aug 2025 - 29 Aug 2025 |
| Margin Keuntungan | -47.87% |
| Margin Operasi (TTM) | -49.16% |
| EPS Cair (TTM) | -0.130 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 43.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 19.39% |
| Nisbah Semasa (MRQ) | 3.99 |
| Aliran Tunai Operasi (OCF TTM) | -12.57 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -10.21 M |
| Pulangan Atas Aset (ROA TTM) | -16.80% |
| Pulangan Atas Ekuiti (ROE TTM) | -35.20% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Distribution (AU) | Bercampur | Bercampur |
| Medical Distribution (Global) | Bercampur | Menurun | |
| Stok | CYCLOPHARM FPO [CYC] | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | -1.5 |
| Osilator Teknikal | -0.5 |
| Purata | -0.38 |
|
Cyclopharm Ltd is a company that engages in the manufacture and sale of medical equipment and radiopharmaceuticals, including associated research and development. It operates through the following segments. The Technegas segment involves supplying diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism, and a distributor of products to the diagnostic imaging sector. The Molecular Imaging segment offers to produce radiopharmaceuticals to be used by physicians in the detection of cancer, neurological disorders, and cardiac disease. The firm generates maximum revenue from the Technegas segment. |
|
| Sektor | Healthcare |
| Industri | Medical Distribution |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 48.68% |
| % Dimiliki oleh Institusi | 21.62% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |